[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367153-105":59,"doc-detail-367153-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","distinctive-circulating-microbial-metagenomic-signatures-in-the-plasma-of-patients-with-lung-cancer-and-their-potential-value-as-molecular-biomarkers","Distinctive circulating microbial metagenomic signatures in the plasma of patients with lung cancer and their potential value as molecular biomarkers","","Lung cancer remains the leading cause of cancer death worldwide. Circulating microbial nucleic acids are promising candidates for cancer liquid biopsy biomarkers, yet their microbial profiles and clinical value in lung cancer have not been well characterized. This study compared plasma from 76 lung cancer patients, additional pancreatic and liver cancer cohorts, and healthy controls using metagenomic whole-genome sequencing, identifying a lung-cancer-specific microbial profile and discriminatory species for biomarker modeling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/distinctive-circulating-microbial-metagenomic-signatures-in-the-plasma-of-patients-with-lung-cancer-and-their-potential-value-as-molecular-biomarkers/367153/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/distinctive-circulating-microbial-metagenomic-signatures-in-the-plasma-of-patients-with-lung-cancer-and-their-potential-value-as-molecular-biomarkers/367153.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study?","Question",{"text":112,"@type":113},"To characterize distinctive circulating microbial metagenomic signatures in the plasma of lung cancer patients and evaluate their potential as molecular biomarkers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the microbial profiles measured?",{"text":117,"@type":113},"Plasma samples were analyzed using metagenomic analyses by whole genome sequencing.",{"name":119,"@type":110,"acceptedAnswer":120},"What key results support biomarker potential?",{"text":121,"@type":113},"Plasma microbial composition differed significantly between lung cancer patients and healthy controls, and a classifier built from five selected species achieved strong AUCs across discovery and validation cohorts.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367153,1790389465,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Chen et al. Journal of Translational Medicine (2025) 23:186  \n[https://doi.org/10.1186/s12967-025-06209-8](https://doi.org/10.1186/s12967-025-06209-8)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nDistinctive circulating microbial    \nmetagenomic signatures in the plasma of patients with lung cancer and their potential value as molecular biomarkers  \nHuijuan Chen1,2 , XueNa Yao1, ChunyanYang3,4,5, Yiran Zhang3, Henan Dong4, Jincheng Zhai4, Dongjie Fan6* and Qiming Zhou5*  \nAbstract  \nLung cancer (LC) remains the leading cause of cancer death globally. Recent reports have suggested that circulating microbial nucleic acids have potential as promising biomarkers for cancer liquid biopsies. However, circulating microbial profiles and their potential clinical value in LC patients remained unexplored. In this study, plasma samples from 76 LC patients, 9 liver cancer patients, 11 pancreatic cancer patients, and 53 healthy controls (HCs) were collected and underwent metagenomic analyses by whole genome sequencing. The composition and relative abundance of the microbial profiles were significantly different between the LC patients and HCs. A distinct plasma-based microbial profile was observed in LC patients. By differential analysis using MaAslin, 40 significant species between LC patients and HCs were identified. Five species were selected as optimal circulating microbial biomarkers for LC. The constructed classifier based on these five species showed an AUC of 0 . 9592, 0 . 9131, and 0.8077 in the discovery, validation, and additional validation cohorts, respectively. Furthermore, metagenomic profiles of 25 lung tumor tissue and plasma paired samples were analyzed and compared. The microbial diversity was significantly increased in plasma compared with the tumor tissue. Among the 13 shared core microbial species, 10 had no difference between the tumor tissue and paired plasma. In conclusion, circulating microbial nucleic acids in the plasma have potential as biomarkers for LC liquid biopsies. The microbiome in the tumor tissue was one of the possible sources of circulating microbial nucleic acids.  \nKeywords Lung cancer, Plasma, Whole genome sequencing, Circulating microbial nucleic acids, Biomarkers  \n*Correspondence: Dongjie Fan [fandongjie@icdc.cn](fandongjie@icdc.cn)[ ](fandongjie@icdc.cn)Qiming Zhou [genbank@vip.sina.com](genbank@vip.sina.com)  \n1 Beijing CapitalBio Medlab Co. Ltd, Beijing 100176, China  \n2 South China Hospital of Shenzhen University, Shenzhen 518111, China  \n3 Beijing SeqTide Gene Technology Co. Ltd, Beijing 10017, China  \n4 Beijing Best HealthCare Medical Technology Co. Ltd, Beijing 100176, China  \n5 School of Life Science and Technology, Harbin Institute of Technology, 92 West Dazhi Street, Harbin 150001, China  \n6 National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a cop","cbCailIValSHytAY","https://ap.wps.com/l/cbCailIValSHytAY","pdf",5006154,13,"English","# Abstract\n# Introduction","[{\"question\":\"What was the main goal of the study?\",\"answer\":\"To characterize distinctive circulating microbial metagenomic signatures in the plasma of lung cancer patients and evaluate their potential as molecular biomarkers.\"},{\"question\":\"How were the microbial profiles measured?\",\"answer\":\"Plasma samples were analyzed using metagenomic analyses by whole genome sequencing.\"},{\"question\":\"What key results support biomarker potential?\",\"answer\":\"Plasma microbial composition differed significantly between lung cancer patients and healthy controls, and a classifier built from five selected species achieved strong AUCs across discovery and validation cohorts.\"}]","Distinctive circulating microbial metagenomic signatures in the plasma of patients with lung cancer and their potential value as molecular biomarkers | PDF",1790169513,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/307f57df2ca9789b1ebeba426c5f77f6.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da7cb5a23aa284ebcc5092893226b021.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be4ebf9a0b565ca48dc1f7f71a0461a1.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61b0328d2b87363fdc1797e368312dc5.webp",980,1301]